References

Adler, R.G. (1992), 'Genome Research: fulfilling the public's expectations for knowledge and commercialization', Science Vol. 257, pp. 908-914.

Blumenthal, D.; Gluck, M.; Louis, KS.; Wise, D. (1986), 'Industrial support of university research in biotechnology', Science Vol. 231, pp. 242—246.

Brasil, Senado Federal (1995), Projeto de Lei No 306, Autoria: Senadora Marina Silva.

Brasil, Congresso Nacional (1995), Lei No 8974, Janeiro.

Brasil, Congresso Nacional (1995b), Projeto de Lei No 1153, Autoria: Deputado Sergio Arouca.

Brasil, Congresso Nacional (1996) Lei No 9279, 14 de Maio.

Brasil, Conselho Nacional de Saude (1996), Resoluçào No. 196 , 10 de Outubro.

Bureau of National Affairs, Inc., (1989) Biotechnology Law for the 1990s: Analysis and Perspective Special Report, N 4.

Caskey, T.; Eisenberg, R.S.; Lander, E.S.; Straus, J., (1995) HUGO Statement on the Patenting of DNA Sequences, Document, The Human Genome Organization, USA.

Champagne, P. and Marchetti, D. (1994), 'L'information médicale sous contrainte. A propos du scandale du sang contaminé', Actes de La Recherche en Sciences Sociales , Mars, pp. 40-62.

Churchill, !.J. (1994), 'Patenting humanity: the development of property rights in the human body and the subsequent evolution of patentability of living things', Intellectual Property Journal Vol. 8, pp.249-284.

Cook-Deegan, R.M., (1994), 'Origins of the Human Genome Project' Risk: Health, Safety & Environment, Vol.5 N.2, pp.97—118.

Crucible Group ( 1994), People, Plants and Patents: the Impact of Intellectual Property on Biodiversity, Conservation, Trade, and Rural Society, The International Development Research Centre, Ottawa, Canada.

Drews, J., (1996) Intent and Coincidence in Drug Research: The Impact of Biotechnology Editiones Roche F.Hoffmann-La Roche Ltd, Basel, Switzerland .

Edelman, B. (1991), 'Expérimentation sur l'homme: une loi sacrificielle', La Recherche Vol. 22, pp. 1056-1065.

Gillam L. (1994), 'Bioethics and public policy in Australia', Politics and the Life Sciences Vol. 3, pp. 87—88.

Hanna, K.E.; Cook-Degan, R.M. and Nishimi, R. (1993) 'Finding a forum for bioethics in U.S. Public Policy', Politics and the Life Sciences Vol. 12, pp. 205-219.

Healy, B., (1992) 'Special Report on Gene Patenting', The New England Journal of Medicine Vol. 327 N. 9, pp. 664-668.

Jasanoff, S. (1995), 'Procedural choices in regulatory science', Technology in Society Vol. 17, pp. 279-293.

Keats, T. (1995), 'Bioethics in Italy', The Lancet Vol. 345, pp. 182.

Kiley, T.D. (1992), 'Patents on random complementary DNA fragments?', Science Vol. 257, pp. 915-918.

Lederberg, J.; Shope, R.E.; Oaks, S.C. (1992), Emerging Infectious: Microbial Threats to Health in the United States. Institute of Medicine, Washington, DC: National Academy Press.

Lenoir, N. (1991), Aux Frontières de ¡a Vie: Une Ethique Biomédicale à la Française , Paris: La Documentation Française.

Marques, M.B. (1994), 'Brazil-US controversy on the impact of patenting in biotechnology: some relevant questions for pharmaceuticals', Science and Public Policy Vol. 21 N. 3, pp. 165—172.

Marques, M.B. (1996a), 'An overview of health-related industrial biotechnology in Latin America and the Caribbean', Bulletin ofPAHO Vol. 30 N.2, pp. 95-105.

Marques, M. B. (1996b), 'In search of a national forum for bioethics in Brazilian public policy', Cadernos de Saúde Publica, Rio de Janeiro, Vol. 12 N. 4, pp. 443—454.

Martínez-Palomo, A. and Sepúlveda, J. (1989), 'Biomedical research in Latin America: old and new challenges', in Bloom B.R. and Cerami A. (ed.) Biomedical Science and the Third World: under the volcano. New York: Annals of The New York Academy of Science Vol. 569, pp. 36-44.

Mervis, J. (1995), 'Conflict of interest: final rules put universities in charge', Science Vol.269, pp.294.

Miller, J. (1994), 'What to do until the philosopher kings come: bioethics and public policy in Canada', Politics and the Life Sciences Vol. 3, pp. 93-95.

Mudurg, G. (1995), 'New rules push researchers closer to biotech industry', Science Vol. 269, pp.297—298.

Nowak, R. (1994), 'Problems in clinical trials go far beyond misconduct', Science Vol. 264, pp. 1538—1541.

Pellegrini Filho, A. (1993), 'La investigación en salud en cinco países de América Latina', Bol Oficina Sanit Panam Vol. 114 N. 2, pp. 142-157.

Polanco, X. (1990), Naissance et développement de la science-monde: production et reproduction des communautés scientifiques en Europe et en Amérique Latine. Paris: UNESCO, Conseil de l'Europe, Editions La Découverte.

Rabino, I. (1994), 'How European and US genetic engineering scientists view the impact of public attention on their field: a comparison', Science, Technology & Human Values Vol. 19 N. 1, pp. 23—46.

Rosenberg, B.H. (1993), 'North vs. South: Politics and the Biological Weapons Convention', Politics and the Life Sciences Vol. 12 N. 1, pp. 69-77.

Santos, R. V. and Coimbra, Jr C. (1996), 'Sangue, bioética e populaçôes indígenas', Parabólicas, Brasil, Boletim do Instituto Sócio-Ambiental, N. 20, Ano 3, Julho.

Shapiro, D. (1994), 'A single national voice for bioethics: reflections from Europe', Politics and the Life Sciences Vol. 3, pp. 98-99.

Swinnerton-Dyer, P. (1995), 'The importance of academic freedom', Nature Vol. 373, pp. 186-188.

USA Congress, Office of Technology Assessment, (1989) New Developments in Biotechnology: Patenting Life—Special Report OTA-BA-370, Washington, DC: Government Printing Office.

USA Congress, Office of Technology Assessment (1991), Biotechnology in a Global Economy OTA-BA-494, Washington, D.C.:U.S. Government Printing Office.

Weinsteim, J.N.; Myers, T.G.; O'Connor, P.M.; Friend, S.H.; Fornace, Jr A.J.; Kohn, K.W.; Fojo, T.; Bates, S.E.; Rubinstein, L.V.; Anderson, N.L.; Buolamwini, J.K.; van Osdol, W.W.; Monks, A.P.; Scudiero, D. A.; Saus-ville, E.A.; Zaharevitz, D.W.; Bunow, B.;Viswanadhan, V.N.; Johnson, G.S.; Wittes, R.R.; Paull, K.D., (1997) 'An information-intensive approach to the molecular pharmacology of cancer'. Science, Vol. 275, pp. 343-349.

Was this article helpful?

0 0

Post a comment